ReviewAntioxidants (Basel, Switzerland)2024

Overview of Clinical Relevance of Antibodies Against Oxidized Low-Density Lipoprotein (oLAb) Within Three Decades by ELISA Technology.

Willibald Wonisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.